Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 025 JPY 0.35% Market Closed
Market Cap: 31.1B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Gross Profit
ÂĄ9.6B
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
5%
Takeda Pharmaceutical Co Ltd
TSE:4502
Gross Profit
ÂĄ3T
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
9%
Daiichi Sankyo Co Ltd
TSE:4568
Gross Profit
ÂĄ1.3T
CAGR 3-Years
26%
CAGR 5-Years
18%
CAGR 10-Years
9%
Otsuka Holdings Co Ltd
TSE:4578
Gross Profit
ÂĄ1.6T
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Gross Profit
ÂĄ805.2B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
13%
Astellas Pharma Inc
TSE:4503
Gross Profit
ÂĄ1.4T
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
5%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
31B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
9.6B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Gross Profit amounts to 9.6B JPY.

What is Daito Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
5%

Over the last year, the Gross Profit growth was -4%. The average annual Gross Profit growth rates for Daito Pharmaceutical Co Ltd have been -4% over the past three years , 2% over the past five years , and 5% over the past ten years .

Back to Top